Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2010-018377-38Phase 4Active
Phase 4, open-label trial of cholera toxin B subunit in cholera (3 arms), sponsored by Leiden University Medical Center. Primary endpoint: Seroconversion rate. Started Jan 2010; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2010-018377-38.